Lightnews — Scholar-powered news

Miguel Perales MD

@drmiguelperales.bsky.social

1.2K followers 590 following 250 posts

Chief Adult BMT MSKCC | Past-President ASTCT | Past Board Member NMDP | Chair Committee Transplant/Cell Ther ALLIANCE | Immigrant 🇪🇸🇬🇧 #MedSky Opinions mine/not MSK https://www.mskcc.org/cancer-care/doctors/miguel-angel-perales

www.mskcc.org

Posts Media Videos Starter Packs

Pinned

Miguel Perales MD @drmiguelperales.bsky.social · Nov 18

Findings highlight ‘critical importance’ of infectious complications after CAR-T - read HemeOncToday interview with Kai Rejeski and me #medsky #CARTcells www.healio.com/news/hematol...

Findings highlight ‘critical importance’ of infectious complications after CAR-T

Infections are the primary cause of nonrelapse mortality among individuals who undergo chimeric antigen receptor T-cell therapy, according to study results.Unique CAR-T-specific side effects — s...

www.healio.com

6 31

Reposted by Miguel Perales MD

HemaSphere Journal @hemasphere-journal.bsky.social · 2d

🎙️New Podcast Episode!

Join host HemaSphere Scientific Editor Dr Charles de Bock as he chats with Dr Kai Rejeski. The conversation delves into the complexities of CAR-T therapy, particularly focusing on the associated toxicities & the need for a structured grading system. 👉https://bit.ly/46xKjZA

Miguel Perales MD @drmiguelperales.bsky.social · 4d

Great session on cGVHD at #COSTEM2025 in Berlin last week. Got to debate Dr. Francesca Kinsella

1 5

Miguel Perales MD @drmiguelperales.bsky.social · 4d

Go see Art on Broadway. Great show!

Miguel Perales MD @drmiguelperales.bsky.social · 6d

Brandenburg Gate #berlin

Reposted by Miguel Perales MD

BMT Infonet @bmtinfonet.bsky.social · 6d

BMT InfoNet invites your patients to a free live webinar with leading CAR T-cell therapy experts.

Encourage your patients and caregivers to register and submit their questions in advance!

🗓 Tuesday, October 21
🕖 7:00 PM ET
🔗 bmtinfonet.org/event/ask-ca...

1 2

Reposted by Miguel Perales MD

Prof Gavin Yamey @gavinyamey.bsky.social · 8d

💉New study of HPV vaccine shows “robust population-level effectiveness & herd protection in adolescent girls & young women”

From 2006-2023:
➡️ Proportion of vaxxed women positive for high-risk HPV-16 & -18 types fell 98.4%, proportion of unvaxxed women fell 71.6%
1/2
jamanetwork.com/journals/jam...

Population-Level Effectiveness and Herd Protection 17 Years After HPV Vaccine

This cross-sectional study investigates population-level effectiveness and herd protection in the first 17 years after human papillomavirus (HPV) vaccination among adolescent girls and young women at ...

jamanetwork.com

22 300 870

Reposted by Miguel Perales MD

NEJM.org @nejm.org · 12d

In a patient with treatment-resistant ulcerative colitis, CD19 CAR T-cell therapy led to drug-free remission and mucosal healing, suggesting that B-cell targeting may offer a novel therapeutic pathway. Read the full report: nej.md/48gcBZV

#MedSky #GastroSky

A graph showing the circulating B-cell counts before and after treatment with blinatumomab and with chimeric antigen receptor (CAR) T cells targeting CD19.

4 17

Reposted by Miguel Perales MD

Liz Szabo @lizszabo.bsky.social · 12d

@bloomberg.com reports that a top advisor to RFK Jr. said they're considering adding autism symptoms to the federal vaccine court program. Read my story for @nbcnews.com on how that could bring a halt to vaccine manufacturing in the U.S.
www.nbcnews.com/health/healt...

RFK Jr. has the federal vaccine court in his sights. Attacking it could threaten vaccine production in the U.S.

The Vaccine Injury Compensation Program created a special court for vaccine-related injuries. Kennedy has called it “broken” and vows to “fix it.”

www.nbcnews.com

1 4 9

Miguel Perales MD @drmiguelperales.bsky.social · 11d

Medical Groups Warn Against Visa Fees for Foreign Doctors www.nytimes.com/2025/09/26/h...

Medical Groups Warn Against Visa Fees for Foreign Doctors

www.nytimes.com

1 3

Reposted by Miguel Perales MD

Kathleen Bachynski @bachynski.bsky.social · 14d

This is huge: “A drug that provides near-perfect protection against H.I.V. with shots just twice a year will be made available at $40 per patient annually in low- and middle-income countries, offering new hope… making lenacapavir a realistic choice in countries with constrained resources.”

Philanthropies Strike a Promising Deal to Turn Back H.I.V.

www.nytimes.com

4 1.3K 4.2K

Reposted by Miguel Perales MD

STAT @statnews.com · 18d

Kennedy says he wants to restore trust in vaccines. His hand-picked ACIP panel raised many doubts, and outside experts were left baffled and frustrated.
www.statnews.com/2025/09/19/w...

In a chaotic meeting, RFK Jr.’s handpicked advisers begin altering the childhood vaccine schedule

Kennedy says he wants to restore trust in vaccines. His hand-picked ACIP panel raised many doubts, and outside experts were left baffled and frustrated.

www.statnews.com

9 34

Reposted by Miguel Perales MD

American Society of Pediatric Hematology/Oncology @aspho-hq.bsky.social · 18d

Today is World Marrow Donor Day! We hope you will join us today in thanking the selfless individuals who register and donate stem cells to save the lives of patients in need. #WMDD25 #PedsHemeOnc #PHODocs #hematology

3 4

Reposted by Miguel Perales MD

Memorial Sloan Kettering Cancer Center @mskcancercenter.bsky.social · 20d

MSK pediatric hematologist-oncologist Dr. Neerav Shukla, who led the research, shares that the testing provides real-time diagnostic, prognostic, and therapeutic information to local physicians and their patients. Learn more ⬇️

MSK Research Highlights, September 4, 2025

New MSK research shows the Make-an-IMPACT program improves global access to genomic testing in pediatric cancer patients; helped develop an experimental antibody that shows promise against metastatic ...

www.mskcc.org

Reposted by Miguel Perales MD

MSK Department of Medicine @mskdeptofmed.bsky.social · 19d

Coming up at #IMS25: Dr. Sham Mailankody will share the results of a phase 1 clinical trial of concurrent BCMA and GPRC5D #CARTcells for relapsed/refractory #multiplemyeloma.

🗓️ Thursday, September 18 | 4:40 p.m. EDT

@mskcancercenter.bsky.social @szusmani.bsky.social @myeloma-society.bsky.social

3 9

Reposted by Miguel Perales MD

MSK Department of Medicine @mskdeptofmed.bsky.social · 18d

At #IMS25, Dr. Francesco Maura will present new research on the genomics that define neoplastic transformation in #multiplemyeloma precursor conditions. #mmsm

🗓️ Saturday, September 20 | 9:20 a.m. EDT

@mskcancercenter.bsky.social @myeloma-society.bsky.social @szusmani.bsky.social

2 4

Reposted by Miguel Perales MD

Eric Topol @erictopol.bsky.social · 17d

Which one is it going to be?
www.economist.com/leaders/2025...
www.nytimes.com/2025/09/14/m...

9 26 120

Reposted by Miguel Perales MD

Dr. Tom Frieden @drtomfrieden.bsky.social · 20d

The announcement of health insurance companies that they’ll continue covering routine vaccinations is a huge vote of no confidence in ACIP's recommendations. It reflects a desire by insurers to avoid the cost of illnesses by having their customers vaccinated.

Gift link:

Questions Are Raised About Vaccine Panel’s Reliability as Policy Review Gets Underway

www.nytimes.com

54 650 2.2K

Reposted by Miguel Perales MD

MSK Department of Medicine @mskdeptofmed.bsky.social · 19d

Coming up at #IMS25: Join MSK's Myeloma Service Chief @szusmani.bsky.social to learn about current challenges in #multiplemyeloma relapse & future research needed to overcome them. #mmsm

🗓️ Friday, September 19 | 9:40 a.m. EDT

@mskcancercenter.bsky.social @myeloma-society.bsky.social

3 5

Reposted by Miguel Perales MD

American Society of Clinical Oncology @ascocancer.bsky.social · 19d

There are 18 million cancer survivors in the U.S. That’s 6x more than there were 50 years ago, thanks to decades of progress driven in large part by federally funded research. We can’t go back.

Take action with us: brnw.ch/21wVV2D
#SaveResearchStopCancer #ASCOAdvocacy

3 3

Reposted by Miguel Perales MD

JCO Journals @jco-asco.bsky.social · 19d

We're thrilled to be here on BlueSky to bring you the latest practice-changing oncology research from all six JCO Journals! Follow-us for great content from #JCO, #JCOOP, #JCOGO, #JCOPO, #JCOCCI, & #JCOOA.

7 12

Reposted by Miguel Perales MD

Memorial Sloan Kettering Cancer Center @mskcancercenter.bsky.social · 28d

🎉 Congrats to MSK's most recent Awards & Appointments honorees, including Dr. Matthew Bott joining the @lcrf.org Scientific Advisory Board and Dr. Martin Weiser, Dr. Julio Garcia-Aguilar, and Dr. Emmanouil Pappou for being named 2025 America’s Leading Doctors in Colorectal Surgery by @newsweek.com.

MSK Awards and Appointments August 2025

Memorial Sloan Kettering Cancer Center (MSK) today announced the following awards and appointments: Matthew Bott Joins the Lung Cancer Research Foundation Scientific Advisory Board

www.mskcc.org

1 1

Reposted by Miguel Perales MD

Memorial Sloan Kettering Cancer Center @mskcancercenter.bsky.social · Sep 7

MSK’s Gerstner Sloan Kettering Graduate School of Biomedical Sciences is now accepting applications for its Cancer Biology and Cancer Engineering #PhD programs for the 2026 academic year. Apply below: